Atlas maps plasma proteins to transform disease diagnosis and treatment

Researchers have developed the most comprehensive atlas linking plasma proteins to diseases and traits in over 53,000 individuals, offering groundbreaking insights for precision medicine. This resource uncovers 168,100 protein-disease associations and identifies new therapeutic targets.

Cell therapy startup A2 Biotherapeutics nets $80M Series C

A2 Biotherapeutics has raised $80 million to run three experimental CAR-T programs for solid tumor cancers. The biotech is developing what it calls logic-gated cell

January 10, 2025

Alzheimer’s Data Withdrawn

A preprint research letter linking the Alzheimer’s drug lecanemab (Leqembi) with excess deaths was withdrawn last week. The preprint was posted on Research Square and

November 12, 2024

Hospitals Unhappy With New Requirement to Report Bed Capacity and COVID Count

Starting next month, hospitals will be required by CMS to report their overall bed capacity as well as their census of patients with respiratory illnesses,

October 15, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.